| Clinicopathological Correlates of Activating GNAS Mutations in Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas M Dal Molin, H Matthaei, J Wu, A Blackford, M Debeljak, N Rezaee, ... Annals of surgical oncology 20, 3802-3808, 2013 | 181 | 2013 |
| Clinical Validation of KRAS, BRAF, and EGFR Mutation Detection Using Next-Generation Sequencing MT Lin, SL Mosier, M Thiess, KF Beierl, M Debeljak, LH Tseng, G Chen, ... American journal of clinical pathology 141 (6), 856-866, 2014 | 159 | 2014 |
| Circulating tumor DNA as a clinical test in resected pancreatic cancer VP Groot, S Mosier, AA Javed, JA Teinor, G Gemenetzis, D Ding, ... Clinical Cancer Research 25 (16), 4973-4984, 2019 | 140 | 2019 |
| Genomic characterization of malignant progression in neoplastic pancreatic cysts M Noë, N Niknafs, CG Fischer, WM Hackeng, V Beleva Guthrie, ... Nature communications 11 (1), 4085, 2020 | 104 | 2020 |
| KRAS and guanine nucleotide-binding protein mutations in pancreatic juice collected from the duodenum of patients at high risk for neoplasia undergoing endoscopic ultrasound JR Eshleman, AL Norris, Y Sadakari, M Debeljak, M Borges, C Harrington, ... Clinical Gastroenterology and Hepatology 13 (5), 963-969. e4, 2015 | 80 | 2015 |
| False positives in multiplex PCR-based next-generation sequencing have unique signatures CM McCall, S Mosier, M Thiess, M Debeljak, A Pallavajjala, K Beierl, ... The Journal of Molecular Diagnostics 16 (5), 541-549, 2014 | 59 | 2014 |
| GNAS codon 201 mutations are uncommon in intraductal papillary neoplasms of the bile duct H Matthaei, J Wu, M Dal Molin, M Debeljak, P Lingohr, N Katabi, ... Hpb 14 (10), 677-683, 2012 | 48 | 2012 |
| Patients with McCune-Albright syndrome have a broad spectrum of abnormalities in the gastrointestinal tract and pancreas LD Wood, M Noë, W Hackeng, LAA Brosens, F Bhaijee, M Debeljak, J Yu, ... Virchows Archiv 470, 391-400, 2017 | 46 | 2017 |
| Metanephric Adenoma–Epithelial Wilms Tumor Overlap Lesions: An Analysis of: BRAF: Status SE Wobker, A Matoso, CA Pratilas, S Mangray, G Zheng, MT Lin, ... The American Journal of Surgical Pathology 43 (9), 1157-1169, 2019 | 25 | 2019 |
| Haplotype counting by next-generation sequencing for ultrasensitive human DNA detection M Debeljak, DN Freed, JA Welch, L Haley, K Beierl, BS Iglehart, ... The Journal of Molecular Diagnostics 16 (5), 495-503, 2014 | 24 | 2014 |
| A virtual pyrogram generator to resolve complex pyrosequencing results G Chen, MT Olson, A O'Neill, A Norris, K Beierl, S Harada, M Debeljak, ... The Journal of Molecular Diagnostics 14 (2), 149-159, 2012 | 24 | 2012 |
| Morphology and genetics of pyloric gland adenomas in familial adenomatous polyposis WM Hackeng, EA Montgomery, FM Giardiello, AD Singhi, M Debeljak, ... Histopathology 70 (4), 549-557, 2017 | 22 | 2017 |
| KRAS and GNAS mutations in pancreatic juice collected from the duodenum of patients at high risk for neoplasia undergoing endoscopic ultrasound JR Eshleman, AL Norris, Y Sadakari, M Debeljak, M Borges, C Harrington, ... Clinical gastroenterology and hepatology: the official clinical practice …, 2015 | 12 | 2015 |
| Haplotype counting for sensitive chimerism testing: potential for early leukemia relapse detection M Debeljak, E Mocci, MC Morrison, A Pallavajjalla, K Beierl, M Amiel, ... The Journal of Molecular Diagnostics 19 (3), 427-436, 2017 | 11 | 2017 |
| Val16a sod2 polymorphism promotes epithelial–mesenchymal transition antagonized by muscadine grape skin extract in prostate cancer cells JD Sweeney, M Debeljak, S Riel, AC Millena, JR Eshleman, CJ Paller, ... Antioxidants 10 (2), 213, 2021 | 6 | 2021 |
| Successful gene therapy requires targeting the vast majority of cancer cells T Sagara, M Debeljak, CM Wright, NM Anders, H Liang, MA Rudek, ... Cancer Biology & Therapy 21 (10), 946-953, 2020 | 2 | 2020 |
| A new fast phasing method based on haplotype subtraction E Mocci, M Debeljak, AP Klein, JR Eshleman The Journal of Molecular Diagnostics 21 (3), 427-436, 2019 | 2 | 2019 |
| Molecular Characterization of Undifferentiated Carcinomas That are Associated With Low-Grade Endometrioid Carcinoma E Kuhn, A Bahadirli-Talbott, A Ayhan, M Debeljak, J Eshleman, C Zhao, ... LABORATORY INVESTIGATION 93, 283A-283A, 2013 | 1 | 2013 |
| Multimodal genome-wide survey of progressing and non-progressing DCIS M Debeljak, S Cho, B Downs, M Considine, B Avin-McKelvey, Y Wang, ... Cancer Research 83 (7_Supplement), 3126-3126, 2023 | | 2023 |
| Analytical Validation of SOD2 Genotyping M Debeljak, S Riel, MT Lin, JR Eshleman, CJ Paller Methods and Protocols 6 (1), 4, 2022 | | 2022 |
James EshlemanProfessor of Patholgy, Oncology, Johns Hopkins UniversityVerified email at jhmi.edu
